Concepedia
8
Publications
375
Citations
H-Index
2017
Active since
Affiliations
Stanford University(Current)
Veterans Health Administration
University of California, Riverside
University of California, Irvine
Abeona Therapeutics (United States)
Jaron Nazaroff is an author at Stanford University specializing in medicine, dermatology, and patient-reported outcomes.
Top concepts
MedicineDermatologyOutcomes ResearchPatient-reported Outcomes
Publications per year
2017–2025
Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa
Shaundra Eichstadt, M. Barriga, Anusha Ponakala et al. · JCI Insight · 2019 · 106 citations · Full text
Patient-reported outcomes and quality of life in recessive dystrophic epidermolysis bullosa: A global cross-sectional survey
V. Eng, D. Solis, Emily S. Gorell et al. · Journal of the American Academy of Dermatology · 2020 · 77 citations
Patient-reported Outcomes, Outcomes Research, Dermatology +2
Phase 2 trial of a neurokinin-1 receptor antagonist for the treatment of chronic itch in patients with epidermolysis bullosa: A randomized clinical trial
Albert S. Chiou, Sara Choi, M. Barriga et al. · Journal of the American Academy of Dermatology · 2019 · 68 citations · Full text
Clinical characteristics associated with increased wound size in patients with recessive dystrophic epidermolysis bullosa
D. Solis, Emily S. Gorell, Claudia Teng et al. · Pediatric Dermatology · 2021 · 46 citations
Long-term safety and efficacy of gene-corrected autologous keratinocyte grafts for recessive dystrophic epidermolysis bullosa
Jodi So, Jaron Nazaroff, Chinonso V. Iwummadu et al. · Orphanet Journal of Rare Diseases · 2022 · 38 citations · Full text
Rows per page
1–5 of 8